Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation following clopidogrel - Judge, HM; Patil, SB; Buckland, RJ (J Thromb Haemost, 2010)
et al.